Wykoff, Charles C.
Yu, Hannah J.
Avery, Robert L.
Ehlers, Justis P.
Tadayoni, Ramin
Sadda, SriniVas R.
Article History
Received: 28 May 2021
Accepted: 14 June 2021
First Online: 11 January 2022
Competing interests
: The authors report the following conflicts of interest: C.C.W: consultant: Adverum, Aerie Pharmaceuticals, Allergan, Apellis, Arctic Vision, Arrowhead Pharmaceuticals, Bausch + Lomb, Bayer, Bionic Vision Technologies, Chengdu Kanghong Biotechnologies, Clearside Biomedical, EyePoint Pharmaceuticals, Genentech, Gyroscope, IVERIC Bio, Kato Pharmaceuticals, Kodiak Sciences, Long Bridge Medical, NGM Biopharmaceuticals, Novartis, OccuRx, Ocular Therapeutix, ONL Therapeutics, Opthea Limited, Oxurion, Palatin, PolyPhotonix, RecensMedical, Regeneron, RegenXBio, Roche, SAI MedPartners, Takeda, Verana Health; research support: Adverum, Aerie Pharmaceuticals, Aldeyra, Alimera Sciences, Allergan, Amgen, Apellis, Asclepix, Bayer, Boehringer Ingelheim, Chengdu Kanghong Biotechnology, Clearside Biomedical, Gemini, Genentech, Graybug Vision, Gyroscope, IONIS Pharmaceutical, iRENIX, IVERIC bio, Kodiak Sciences, LMRI, Neurotech Pharmaceuticals, NGM Biopharmaceuticals, Novartis, Oxurion, RecensMedical, Regeneron, RegenXBio, Roche, SamChunDang Pharm, Taiwan Liposome Company, Xbrane BioPharma; ownership/stock: ONL Therapeutics, PolyPhotonix, RecensMedical, Visgenx. H.J.Y: No conflicts of interest. R.L.A: consultant: Allergan, Alimera, Amgen, Bausch & Lomb, Ocular Therapeutix, Iridex, Novartis, Regeneron, RegenXbio, Santen, Genentech, and Eyepoint; stock: Novartis, Regeneron, Replenish. J.P.E: <i>Consultant</i>: Adverum, Aerpio, Alcon, Allegro, Allergan, Genentech/Roche, Leica, Novartis, Regeneron, Santen, Stealth, Thrombogenics, Zeiss; research support: Aerpio, Alcon, Allergan, Novartis, Regeneron, Thrombogenics; <i>Patents</i>: Leica. R.T: <i>Consultant</i>: Allergan, Alcon, Apellis, Bayer, Genentech, Iveric Bio, Chengdu Kanghong Biotechnologies, Novartis, Oculis, Roche, Thea, Zeiss; <i>Research Support</i>: Allergan, Bayer, Genentech, Chengdu Kanghong Biotechnologies, Novartis, Oculis, Roche. S.R.S: <i>Consultant</i>: Amgen, Allergan, Apellis, Genentech/Roche, Oxurion, Novartis, Regeneron, Bayer, 4DMT, Centervue, Heidelberg, Optos; research support: Carl Zeiss Meditec, Heidelberg Engineering, Optos; research instruments: Nidek, Topcon, Heidelberg, Carl Zeiss Meditec, Optos, Centervue.